These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
320 related items for PubMed ID: 2539403
21. [Comparison of lisinopril and captopril in treatment of severe heart failure (NYHA III-IV) in high risk patients. Preliminary results of the trial]. Risler T, Braun U, Klärner HG, Müller-Schauenburg W, Heitkamp HC, Brilla GG, Krämer BK, Seipel L. Z Kardiol; 1991; 80 Suppl 2():40-3. PubMed ID: 1850942 [Abstract] [Full Text] [Related]
22. Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor. van den Broek SA, de Graeff PA, Smit AJ, Girbes AR, Journée, van Gilst WH, Hillege H, van Veldhuisen DJ, Wesseling H, Lie KI. J Cardiovasc Pharmacol; 1995 Jan; 25(1):105-12. PubMed ID: 7723338 [Abstract] [Full Text] [Related]
23. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. Majumdar SR, McAlister FA, Cree M, Chang WC, Packer M, Armstrong PW, ATLAS Study Group. Clin Ther; 2004 May; 26(5):694-703. PubMed ID: 15220013 [Abstract] [Full Text] [Related]
24. Comparison of lisinopril versus digoxin for congestive heart failure during maintenance diuretic therapy. The Lisinopril-Digoxin Study Group. Herlitz J. Am J Cardiol; 1992 Oct 08; 70(10):84C-90C. PubMed ID: 1329479 [Abstract] [Full Text] [Related]
25. Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure. Pacher R, Stanek B, Globits S, Berger R, Hülsmann M, Wutte M, Frey B, Schuller M, Hartter E, Ogris E. Eur Heart J; 1996 Aug 08; 17(8):1223-32. PubMed ID: 8869864 [Abstract] [Full Text] [Related]
26. Comparison of treatment with lisinopril versus enalapril for congestive heart failure. Zannad F, van den Broek SA, Bory M. Am J Cardiol; 1992 Oct 08; 70(10):78C-83C. PubMed ID: 1329478 [Abstract] [Full Text] [Related]
28. Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect. Garavaglia GE, Messerli FH, Nunez BD, Schmieder RE, Frohlich ED. Am J Hypertens; 1988 Jul 08; 1(3 Pt 3):214S-216S. PubMed ID: 2843195 [Abstract] [Full Text] [Related]
29. Clinical and neurohormonal effects of nicardipine hydrochloride in patients with severe chronic heart failure receiving angiotensin-converting enzyme inhibitor therapy. Benatar D, Hall V, Reddy S, Gheorghiade M. Am J Ther; 1998 Jan 08; 5(1):25-32. PubMed ID: 10099034 [Abstract] [Full Text] [Related]
30. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial. Rouleau JL, Pfeffer MA, Stewart DJ, Isaac D, Sestier F, Kerut EK, Porter CB, Proulx G, Qian C, Block AJ. Lancet; 2000 Aug 19; 356(9230):615-20. PubMed ID: 10968433 [Abstract] [Full Text] [Related]
31. Lisinopril: a review of its use in congestive heart failure. Simpson K, Jarvis B. Drugs; 2000 May 19; 59(5):1149-67. PubMed ID: 10852646 [Abstract] [Full Text] [Related]
32. Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responses. Uretsky BF, Shaver JA, Liang CS, Amin D, Shah PK, Levine TB, Walinsky P, LeJemtel T, Linnemeier T, Rush JE. Am Heart J; 1988 Aug 19; 116(2 Pt 1):480-8. PubMed ID: 2840815 [Abstract] [Full Text] [Related]
33. Role of angiotensin-converting enzyme inhibitors in congestive heart failure. Galvao M. Heart Lung; 1990 Sep 19; 19(5 Pt 1):505-11. PubMed ID: 2211159 [Abstract] [Full Text] [Related]
34. Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients. Langtry HD, Markham A. Drugs Aging; 1997 Feb 19; 10(2):131-66. PubMed ID: 9061270 [Abstract] [Full Text] [Related]
35. Duration of angiotensin-converting enzyme inhibition: implications for tolerability. Murray NH. Cardiology; 1991 Feb 19; 79 Suppl 1():22-9. PubMed ID: 1655262 [Abstract] [Full Text] [Related]
36. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct 19; 14(79):180-6. PubMed ID: 16285075 [Abstract] [Full Text] [Related]
37. Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure. O'Toole L, Stewart M, Padfield P, Channer K. J Cardiovasc Pharmacol; 1998 Dec 19; 32(6):988-94. PubMed ID: 9869506 [Abstract] [Full Text] [Related]
38. Effects of lisinopril in patients with heart failure and chronic atrial fibrillation. Van Den Berg MP, Crijns HJ, Van Veldhuisen DJ, Griep N, De Kam PJ, Lie KI. J Card Fail; 1995 Dec 19; 1(5):355-63. PubMed ID: 12836710 [Abstract] [Full Text] [Related]
39. [Lisinopril in the treatment of heart insufficiency]. Barcina Sánchez C, Martín Cortés M, Fernández Fernández A. An Med Interna; 1995 May 19; 12(5):246-53. PubMed ID: 7669880 [Abstract] [Full Text] [Related]
40. Acute haemodynamic effects of lisinopril and captopril in patients with severe congestive heart failure. Van Mieghem W, Van Hedent T, Byttebier G. Acta Cardiol; 1993 May 19; 48(1):43-53. PubMed ID: 8383397 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]